Example: Heart Attack

Clinical Trials on Long QT Syndrome 3

Total 6 results

    • NCT02014961
      Recruiting
      Worm Study: Modifier Genes in Sudden Cardiac Death
      Conditions: Brugada Syndrome; Long QT Syndrome 3
    • NCT01648205
      Completed
      Efficacy Study of Sodium Channel Blocker in LQT3 Patients
      Conditions: Long QT Syndrome
    • NCT01728025
      Unknown status
      Long Term Prophylactic Therapy of Congenital Long QT Syndrome Type III (LQT3) With Ranolazine
      Conditions: Long QT Syndrome Type 3
    • NCT01849003
      Completed
      Study of the Effect of GS-6615 in Subjects With LQT-3
      Conditions: Long QT Syndrome
    • NCT02300558
      Terminated
      Effect of Eleclazine on Shortening of the QT Interval, Safety, and Tolerability in Adults With Long QT Syndrome Type 3
      Conditions: Long QT Syndrome Type 3
    • NCT02436798
      Recruiting
      5-HT3 Antagonists (Antiemetics) and Cardiac Safety
      Conditions: Adverse Reaction to Other Drugs and Medicines
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations